loadpatents
name:-0.0019180774688721
name:-0.0014820098876953
name:-0.006382942199707
Wang; Duncheng Patent Filings

Wang; Duncheng

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wang; Duncheng.The latest application filed is for "combination therapy of acellular pro-tolerogenic and pro-inflammatory preparations for modulating the immune system".

Company Profile
4.7.9
  • Wang; Duncheng - Greenville NC
  • Wang; Duncheng - Vancouver CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Acellular pro-inflammatory compositions, process for making same and methods of using same
Grant 11,007,221 - Scott , et al. May 18, 2
2021-05-18
Combination Therapy of Acellular Pro-Tolerogenic and Pro-Inflammatory Preparations for Modulating the Immune System
App 20200147133 - Scott; Mark D. ;   et al.
2020-05-14
Combination therapy of acellular pro-tolerogenic and pro-inflammatory preparations for modulating the immune system
Grant 10,561,685 - Scott , et al. Feb
2020-02-18
Method for inducing immune tolerance using non-proliferative polymer-modified allogeneic leukocytes
Grant 10,188,681 - Scott , et al. Ja
2019-01-29
Acellular pro-tolerogenic compositions for the treatment/prevention of auto-immune diseases
Grant 10,039,787 - Scott , et al. August 7, 2
2018-08-07
Acellular pro-tolerogenic compositions for treatment/prevention of graft rejection
Grant 10,039,788 - Scott , et al. August 7, 2
2018-08-07
Acellular pro-tolerogenic compositions and process for making same
Grant 10,039,786 - Scott , et al. August 7, 2
2018-08-07
Combination Therapy of Acellular Pro-Tolerogenic and Pro-Inflammatory Preparations for Modulating the Immune System
App 20170173078 - Scott; Mark D. ;   et al.
2017-06-22
Method for inducing immune tolerance using viable polymer-modified allogeneic leukocytes
Grant 9,498,496 - Scott , et al. November 22, 2
2016-11-22
Acellular Pro-inflammatory Compositions, Process For Making Same And Methods Of Using Same
App 20160206655 - SCOTT; Mark D. ;   et al.
2016-07-21
Method for Inducing Immune Tolerance Using Non-Proliferative Polymer-Modified Allogeneic Leukocytes
App 20150209387 - Scott; Mark D. ;   et al.
2015-07-30
Method for Inducing Immune Stimulation Using Non-Proliferative Allogeneic Leukocytes
App 20150202229 - Scott; Mark D. ;   et al.
2015-07-23
Acellular Pro-Tolerogenic Compositions for Treatment/Prevention of Graft Rejection
App 20150196597 - Scott; Mark D. ;   et al.
2015-07-16
Acellular Pro-Tolerogenic Compositions and Process for Making Same
App 20150174168 - Scott; Mark D. ;   et al.
2015-06-25
Acellular Pro-Tolerogenic Compositions for the Treatment/Prevention of Auto-Immune Diseases
App 20150164948 - Scott; Mark D. ;   et al.
2015-06-18
Method for Inducing Immune Tolerance Using Viable Polymer-Modified Allogeneic Leukocytes
App 20140017218 - Scott; Mark D. ;   et al.
2014-01-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed